Breaking News, Promotions & Moves

BrainStorm Cell Therapeutics Names New EVP & COO

Dr. Hartoun Hartounian brings over 32 years of experience in the biopharmaceutical industry, with a focus on cell and gene therapy.

Author Image

By: Charlie Sternberg

Associate Editor

BrainStorm Cell Therapeutics Inc., a developer of adult stem cell therapeutics for neurodegenerative diseases, has appointed Hartoun Hartounian Ph.D. as its new EVP and COO, effective June 18, 2024.   Hartounian brings a distinguished track record with over 32 years of experience in the biopharmaceutical industry, with a focus on cell and gene therapy. His career highlights include founding and leading BioCentriq, a cell and gene therapy CDMO facility, which was successfully acquired for $73 m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters